1. Home
  2. CGEM vs RRBI Comparison

CGEM vs RRBI Comparison

Compare CGEM & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • RRBI
  • Stock Information
  • Founded
  • CGEM 2016
  • RRBI 1998
  • Country
  • CGEM United States
  • RRBI United States
  • Employees
  • CGEM N/A
  • RRBI N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • RRBI Hotels/Resorts
  • Sector
  • CGEM Health Care
  • RRBI Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • RRBI Nasdaq
  • Market Cap
  • CGEM 437.2M
  • RRBI 455.8M
  • IPO Year
  • CGEM 2021
  • RRBI 2019
  • Fundamental
  • Price
  • CGEM $8.53
  • RRBI $65.42
  • Analyst Decision
  • CGEM Strong Buy
  • RRBI Buy
  • Analyst Count
  • CGEM 7
  • RRBI 1
  • Target Price
  • CGEM $26.00
  • RRBI $67.00
  • AVG Volume (30 Days)
  • CGEM 793.3K
  • RRBI 43.9K
  • Earning Date
  • CGEM 11-06-2025
  • RRBI 10-30-2025
  • Dividend Yield
  • CGEM N/A
  • RRBI 0.91%
  • EPS Growth
  • CGEM N/A
  • RRBI 26.56
  • EPS
  • CGEM N/A
  • RRBI 6.01
  • Revenue
  • CGEM N/A
  • RRBI $118,909,000.00
  • Revenue This Year
  • CGEM N/A
  • RRBI $7.17
  • Revenue Next Year
  • CGEM N/A
  • RRBI $15.07
  • P/E Ratio
  • CGEM N/A
  • RRBI $10.99
  • Revenue Growth
  • CGEM N/A
  • RRBI 11.93
  • 52 Week Low
  • CGEM $5.68
  • RRBI $46.33
  • 52 Week High
  • CGEM $14.15
  • RRBI $69.40
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 58.64
  • RRBI 47.45
  • Support Level
  • CGEM $7.93
  • RRBI $64.86
  • Resistance Level
  • CGEM $9.10
  • RRBI $69.18
  • Average True Range (ATR)
  • CGEM 0.66
  • RRBI 1.75
  • MACD
  • CGEM 0.07
  • RRBI -0.14
  • Stochastic Oscillator
  • CGEM 77.20
  • RRBI 21.57

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: